German-based Merck Serono and Indian company Lupin recently became partners. Lupin will manufacturer products that will be marketed by Merck Serono in developing markets.

The list of 20 new products include cardiovascular, diabetes and antibacterial drugs. These will be sold in Brazil, Mexico, Indonesia, Philippines, Africa and Europe. The first product will be launched in 2016.

 

Source: Remedium